Scott Adams Urgently Seeks Trump’s Help for Cancer Treatment

URGENT UPDATE: Scott Adams, the creator of “Dilbert,” has made a desperate plea to former President Donald Trump for assistance with his health insurance provider regarding a vital cancer treatment. Just announced today, Adams revealed that despite receiving approval from Kaiser Permanente of Northern California for Pluvicto—a newly FDA-approved drug for metastasized prostate cancer—he is still waiting for the scheduled IV infusion.

“I am declining fast,” Adams posted on X (formerly Twitter), expressing the critical need for action. He directly asked Trump to intervene and ensure the treatment is scheduled for Monday, stating that it could give him a fighting chance to extend his life.

In response, Health and Human Services Secretary Robert F. Kennedy Jr. reached out within hours, indicating the President’s readiness to help. “The President wants to help,” Kennedy tweeted, asking Adams how to make contact. Trump himself acknowledged the situation on Truth Social, posting, “On it!”

White House Deputy Chief of Staff Dan Scavino assured Adams that immediate action was underway, stating, “@realDonaldTrump, @RobertKennedyJr., and @DrOz are all tracking now, Scott.”

Adams first disclosed his cancer diagnosis earlier this year and has been vocal about his struggles, including daily pain and reliance on a walker for mobility. Prostate cancer, as reported by the American Cancer Society, impacts one in eight American men throughout their lives and is the second leading cause of cancer-related deaths among men, following lung cancer.

This developing situation highlights the urgent intersection of health care and political influence, as many are watching closely to see how quickly Adams can receive the necessary treatment. The emotional weight of his plea resonates with countless individuals facing similar battles.

As the urgency escalates, further updates are anticipated regarding the response from Kaiser Permanente and the actions taken by Trump and his team. Stay tuned for more breaking news on this critical health story.